Bristol-Myers Squibb Company
BMY
$56.45
$0.781.40%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.49B | 12.50B | 12.22B | 12.27B | 11.20B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.49B | 12.50B | 12.22B | 12.27B | 11.20B |
| Cost of Revenue | 3.41B | 3.51B | 3.31B | 3.36B | 3.02B |
| Gross Profit | 8.08B | 9.00B | 8.91B | 8.91B | 8.18B |
| SG&A Expenses | 1.61B | 2.09B | 1.79B | 1.69B | 1.58B |
| Depreciation & Amortization | 437.00M | 826.00M | 831.00M | 830.00M | 830.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.69B | 8.98B | 8.36B | 8.14B | 7.67B |
| Operating Income | 3.80B | 3.52B | 3.86B | 4.13B | 3.54B |
| Income Before Tax | 3.24B | 1.47B | 3.11B | 1.77B | 2.97B |
| Income Tax Expenses | 561.00M | 384.00M | 919.00M | 460.00M | 509.00M |
| Earnings from Continuing Operations | 2.68B | 1.09B | 2.20B | 1.31B | 2.46B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.00M | 1.00M | 6.00M | -2.00M | -6.00M |
| Net Income | 2.68B | 1.09B | 2.20B | 1.31B | 2.46B |
| EBIT | 3.80B | 3.52B | 3.86B | 4.13B | 3.54B |
| EBITDA | 4.41B | 4.55B | 4.91B | 5.12B | 4.55B |
| EPS Basic | 1.31 | 0.53 | 1.08 | 0.64 | 1.21 |
| Normalized Basic EPS | 1.12 | 1.19 | 1.25 | 1.29 | 1.14 |
| EPS Diluted | 1.31 | 0.53 | 1.08 | 0.64 | 1.20 |
| Normalized Diluted EPS | 1.12 | 1.18 | 1.25 | 1.29 | 1.13 |
| Average Basic Shares Outstanding | 2.04B | 2.04B | 2.04B | 2.04B | 2.03B |
| Average Diluted Shares Outstanding | 2.05B | 2.04B | 2.04B | 2.04B | 2.04B |
| Dividend Per Share | 0.63 | 0.63 | 0.62 | 0.62 | 0.62 |
| Payout Ratio | 47.93% | 116.10% | 57.38% | 96.34% | 51.22% |